# ARCA biopharma, Inc.: Form D filings

ARCA biopharma, Inc., a pharmaceuticals company in Westminster, CO, filed 8 Form D notices with the SEC between 2009 and 2015. The latest, on June 25, 2015, reports $51.7 million sold of a $51.7 million offering to 14 investors.

Find out what ARCA biopharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ARCA%20biopharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ARCA%20biopharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Farca-biopharma-inc-907654)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ARCA%20biopharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ARCA%20biopharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Farca-biopharma-inc-907654)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 11080 CIRCLEPOINT ROAD, SUITE 140, Westminster, CO, 80020
- Phone: (720) 940-2200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 907654

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 25, 2015 | New notice | $51,650,404 | $51,650,404 | $0 | 14 | Jun 16, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000090765415000002/0000907654-15-000002-index.htm) |
| Feb 20, 2014 | New notice | $326,158 | $326,158 | $0 | 2 | Feb 7, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000150055314000001/0001500553-14-000001-index.htm) |
| Jun 17, 2013 | New notice | $1,250,000 | $1,250,000 | $0 | 2 | Jun 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000142850013000002/0001428500-13-000002-index.htm) |
| Feb 1, 2013 | New notice | $1,000,000 | $1,000,000 | $0 | 5 | Jan 25, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000147829713000001/0001478297-13-000001-index.htm) |
| Dec 28, 2012 | New notice | $250,000 | $250,000 | $0 | 1 | Dec 18, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000143750512000003/0001437505-12-000003-index.htm) |
| Oct 31, 2012 | New notice | $325,000 | $325,000 | $0 | 4 | Oct 22, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000143750512000002/0001437505-12-000002-index.htm) |
| Jan 5, 2012 | New notice | $4,549,285 | $4,549,285 | $0 | 6 | Dec 22, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000142850012000001/0001428500-12-000001-index.htm) |
| Oct 26, 2009 | New notice | $499,999 | $499,999 | $0 | 1 | Oct 18, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/907654/000134441309000003/0001344413-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Christopher D. Ozeroff | Executive Officer |  |
| Thomas A. Keuer | Executive Officer |  |
| Raymond L. Woosley | Director |  |
| Linda S. Grais | Director |  |
| Dan J. Mitchell | Director |  |
| Brian L. Selby | Executive Officer |  |
| Robert E. Conway | Director |  |
| Michael R. Bristow | Executive Officer, Director |  |

[Every Form D from the week of Jun 22, 2015](https://specstream.ai/data/form-d/week/2015-06-22) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ARCA biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).